Robert Hofmeister - Net Worth and Insider Trading
Robert Hofmeister Net Worth
The estimated net worth of Robert Hofmeister is at least $57,498 dollars as of 2024-11-13. Robert Hofmeister is the Chief Scientific Officer of TCR2 Therapeutics Inc and owns about 38,850 shares of TCR2 Therapeutics Inc (TCRR) stock worth over $57,498. Details can be seen in Robert Hofmeister's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Hofmeister has not made any transactions after 2020-11-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert Hofmeister
Robert Hofmeister Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert Hofmeister owns 2 companies in total, including TCR2 Therapeutics Inc (TCRR) , and Alaunos Therapeutics Inc (TCRT) .
Click here to see the complete history of Robert Hofmeister’s form 4 insider trades.
Insider Ownership Summary of Robert Hofmeister
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TCRR | TCR2 Therapeutics Inc | 2020-11-12 | Chief Scientific Officer |
| TCRT | Alaunos Therapeutics Inc | 2023-03-30 | director |
Robert Hofmeister Latest Holdings Summary
Robert Hofmeister currently owns a total of 1 stock. Robert Hofmeister owns 38,850 shares of TCR2 Therapeutics Inc (TCRR) as of November 12, 2020, with a value of $57,498.
Latest Holdings of Robert Hofmeister
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TCRR | TCR2 Therapeutics Inc | 2020-11-12 | 38,850 | 1.48 | 57,498 |
Holding Weightings of Robert Hofmeister
Robert Hofmeister Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert Hofmeister has made a total of 2 transactions in TCR2 Therapeutics Inc (TCRR) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in TCR2 Therapeutics Inc is the sale of 20,000 shares on November 12, 2020, which brought Robert Hofmeister around $502,000.
Insider Trading History of Robert Hofmeister
- 1
Robert Hofmeister Trading Performance
Robert Hofmeister Ownership Network
Ownership Network List of Robert Hofmeister
Ownership Network Relation of Robert Hofmeister
Robert Hofmeister Owned Company Details
What does TCR2 Therapeutics Inc do?
Who are the key executives at TCR2 Therapeutics Inc?
Robert Hofmeister is the Chief Scientific Officer of TCR2 Therapeutics Inc. Other key executives at TCR2 Therapeutics Inc include 10 percent owner Kevin C Tang , director & 10 percent owner Ansbert Gadicke , and 10 percent owner Mpm Asset Management Llc .
TCR2 Therapeutics Inc (TCRR) Insider Trades Summary
Over the past 18 months, Robert Hofmeister made no insider transaction in TCR2 Therapeutics Inc (TCRR). Other recent insider transactions involving TCR2 Therapeutics Inc (TCRR) include a net sale of 70,170 shares made by Mpm Asset Management Llc , a net sale of 70,170 shares made by Ansbert Gadicke , and a net purchase of 50,000 shares made by Kevin C Tang .
In summary, during the past 3 months, insiders sold 0 shares of TCR2 Therapeutics Inc (TCRR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 140,340 shares of TCR2 Therapeutics Inc (TCRR) were sold and 50,000 shares were bought by its insiders, resulting in a net sale of 90,340 shares.
TCR2 Therapeutics Inc (TCRR)'s detailed insider trading history can be found in Insider Trading Tracker table.
TCR2 Therapeutics Inc Insider Transactions
Robert Hofmeister Mailing Address
Above is the net worth, insider trading, and ownership report for Robert Hofmeister. You might contact Robert Hofmeister via mailing address: C/o Tcr2 Therapeutics Inc., 100 Binney Street, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
